Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -2.6e-05 | 1 |